EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC

Feixiang Xiong, Xuejie Zhang iD, Dandan Chen, Yang Zhou, Peipei Meng, Fengna Yan, Yixin Hou

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-14

DOI: 10.2147/jhc.s620276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Feixiang Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

etiologyimmunotherapymetabolic-associated steatohepatitis related hepatocellular carcinoma

Autor:innen und Institutionen

  • Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Beijing Institute of Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Beijing Key Laboratory of Viral Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.

ORCID-Profile: Xuejie Zhang

Zitieren

APA

Xiong, F., Zhang, X., Chen, D., Zhou, Y., Meng, P., Yan, F., & Hou, Y. (2026). Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s620276

Vancouver

Xiong F, Zhang X, Chen D, Zhou Y, Meng P, Yan F, et al. Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s620276

BibTeX
@article{Xiong2026,
  author = {Xiong, Feixiang and Zhang, Xuejie and Chen, Dandan and Zhou, Yang and Meng, Peipei and Yan, Fengna and Hou, Yixin},
  title = {Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--14},
  doi = {10.2147/jhc.s620276}
}
Kostenlos starten →